Slow Capital Inc. Has $13.40 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Slow Capital Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 39,711 shares of the medical equipment provider’s stock after acquiring an additional 40 shares during the quarter. Intuitive Surgical comprises 2.3% of Slow Capital Inc.’s holdings, making the stock its 12th largest holding. Slow Capital Inc.’s holdings in Intuitive Surgical were worth $13,397,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. increased its holdings in Intuitive Surgical by 0.7% in the third quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock worth $8,730,184,000 after purchasing an additional 196,316 shares in the last quarter. Geode Capital Management LLC increased its holdings in Intuitive Surgical by 1.0% in the first quarter. Geode Capital Management LLC now owns 6,444,995 shares of the medical equipment provider’s stock worth $1,642,287,000 after purchasing an additional 61,659 shares in the last quarter. Morgan Stanley increased its holdings in Intuitive Surgical by 29.9% in the fourth quarter. Morgan Stanley now owns 5,866,613 shares of the medical equipment provider’s stock worth $1,556,706,000 after purchasing an additional 1,351,002 shares in the last quarter. Jennison Associates LLC increased its holdings in Intuitive Surgical by 6.4% in the third quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock worth $1,340,205,000 after purchasing an additional 274,692 shares in the last quarter. Finally, Invesco Ltd. increased its holdings in Intuitive Surgical by 6.6% in the third quarter. Invesco Ltd. now owns 3,750,490 shares of the medical equipment provider’s stock worth $1,096,231,000 after purchasing an additional 232,205 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 1.7 %

ISRG stock traded down $6.49 during midday trading on Wednesday, hitting $372.06. The company’s stock had a trading volume of 702,784 shares, compared to its average volume of 1,622,154. The stock’s 50-day moving average price is $387.90 and its 200 day moving average price is $342.17. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76. The stock has a market cap of $131.88 billion, a price-to-earnings ratio of 75.01, a PEG ratio of 5.86 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.48 by $0.12. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The business had revenue of $1.93 billion for the quarter, compared to analysts’ expectations of $1.89 billion. During the same quarter in the previous year, the firm earned $0.91 earnings per share. The business’s revenue was up 16.6% on a year-over-year basis. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.20, for a total transaction of $740,400.00. Following the transaction, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,373,093.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, VP Fredrik Widman sold 5,041 shares of the business’s stock in a transaction on Friday, March 15th. The stock was sold at an average price of $397.07, for a total transaction of $2,001,629.87. Following the sale, the vice president now directly owns 110 shares in the company, valued at approximately $43,677.70. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction on Friday, January 26th. The shares were sold at an average price of $370.20, for a total value of $740,400.00. Following the sale, the director now owns 25,319 shares in the company, valued at $9,373,093.80. The disclosure for this sale can be found here. Insiders have sold 248,418 shares of company stock valued at $95,927,097 in the last 90 days. Insiders own 0.80% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of research analyst reports. Citigroup lifted their target price on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Truist Financial boosted their price objective on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, January 24th. Barclays boosted their price objective on Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a report on Thursday, January 25th. Stifel Nicolaus boosted their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. Finally, Royal Bank of Canada boosted their price objective on Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a report on Wednesday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $375.70.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.